Financing drug discovery via dynamic leverage

We extend the megafund concept for funding drug discovery to enable dynamic leverage in which the portfolio of candidate therapeutic assets is predominantly financed initially by equity, and debt is introduced gradually as assets mature and begin generating cash flows. Leverage is adjusted so as to...

Full description

Bibliographic Details
Main Authors: Frishkopf, John J. (Author), Montazerhodjat, Vahid (Contributor), Lo, Andrew W (Contributor)
Other Authors: Massachusetts Institute of Technology. Computer Science and Artificial Intelligence Laboratory (Contributor), Massachusetts Institute of Technology. Department of Electrical Engineering and Computer Science (Contributor)
Format: Article
Language:English
Published: Elsevier, 2017-05-16T15:25:32Z.
Subjects:
Online Access:Get fulltext